Regorafenib induces adaptive resistance of colorectal cancer cells via inhibition of vascular endothelial growth factor receptor. (Q49711772)
Jump to navigation
Jump to search
scientific article published in January 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Regorafenib induces adaptive resistance of colorectal cancer cells via inhibition of vascular endothelial growth factor receptor. |
scientific article published in January 2017 |
Statements
1 reference
Regorafenib induces adaptive resistance of colorectal cancer cells via inhibition of vascular endothelial growth factor receptor. (English)
1 reference
Chisato Tomida
Hikaru Nagano
Naoko Yamagishi
Takayuki Uchida
Ayako Ohno
Takeshi Nikawa
Shigetada Teshima-Kondo
1 January 2017
1 reference